Karyopharm Therapeutics Inc. (KPTI)
NASDAQ·Healthcare·Biotechnology
$6.87
-3.10%
Mkt Cap $162.72M
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (13 analysts)
$17.25
Range $12.00 – $28.00
Implied Upside
+151.1%
Consensus $17.25 vs current $6.87
NASDAQ·Healthcare·Biotechnology
$6.87
-3.10%
Mkt Cap $162.72M
Buy
6
Hold
0
Sell
0
Price Target (13 analysts)
$17.25
Range $12.00 – $28.00
+151.1%
Consensus $17.25 vs current $6.87